Skip to main content
Clinical Trials/NCT06425601
NCT06425601
Completed
Not Applicable

The Impact of Chest Drain Type on Pain, Drainage Efficacy and Short Term Outcome Following VATS Lobectomy for Lung Cancer: A Prospective Randomized Study Comparing Silicone Versus PVC Drains

University Medical Centre Ljubljana1 site in 1 country80 target enrollmentSeptember 30, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Postoperative Pain
Sponsor
University Medical Centre Ljubljana
Enrollment
80
Locations
1
Primary Endpoint
Analgesics consumption
Status
Completed
Last Updated
last year

Overview

Brief Summary

The goal of this prospective randomized clinical trial is to compare the impact of the chest tube type on pain, chest drainage efficacy and early postoperative outcome following VATS lobectomy for lung cancer.

The main questions it aims to answer are:

  • silicone chest drains are less painful compared to standard PVC drains?
  • is there any difference in chest drainage efficacy and short term outcome between the two groups? Researchers will compare silicone chest drain group with PVC chest drain group to see if there is any difference in postoperative pain, chest drainage efficacy and short term outcome.
Registry
clinicaltrials.gov
Start Date
September 30, 2020
End Date
August 10, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Boris Greif, MD

Head of Thoracic Surgery

University Medical Centre Ljubljana

Eligibility Criteria

Inclusion Criteria

  • primary lung cancer eligible for VATS lobectomy by tumor board meeting

Exclusion Criteria

  • age under 18 years
  • high risk of post-operative complications (ASA \> 3, diffusion capacity for transfer factor (TLCO) or forced expiratory volume at one second (FEV1) ≤ 40%, cycle ergometry with oxygen consumption (VO2 max) \< 15 ml/kg/min)
  • tumors growing in parietal pleura
  • extended lung resection diffuse
  • previous surgery in the same hemithorax
  • chronic pain
  • chronic use of analgesics or sedatives
  • surgical revision
  • inability to participate in the study.

Outcomes

Primary Outcomes

Analgesics consumption

Time Frame: 2 days

Amount of analgesics used first two days after the surgery was analyzed and reported in milligrams. Higher scores mean a worse outcome.

Need for peroral analgesia after the chest tube removal

Time Frame: 2 days

Need for peroral analgesia at first, second and fourth week after chest tube removal was assessed and reported as frequency in number. Higher scores mean a worse outcome.

Visual analogue scale

Time Frame: 2 days

Post-operative pain during the first two days after the surgery was analyzed by using the visual analogue scale (VAS). Scale tittle was Visual Analogue Scale. Minimum value on a scale was 0 and maximum value was 10. Higher scores mean a worse outcome.

Maximal expiratory pressure

Time Frame: 2 days

Post-operative pain during the first two days after the surgery was analyzed by measuring the maximal expiratory pressure (MEP) in cmH2O. Higher scores mean a better outcome.

Maximal inspiratory pressure

Time Frame: 2 days

Post-operative pain during the first two days after the surgery was analyzed by measuring the maximal inspiratory pressure (MIP) in cmH2O. Higher scores mean a better outcome.

Secondary Outcomes

  • Reintervention rate(1 month)
  • Respiratory complication rate(1 month)
  • Duration of chest drainage(1 month)
  • Pneumothorax rate on the day of surgery(First day)
  • Pneumothorax rate after chest tube removal(1 month)
  • Pleural effusion rate on the day of surgery(First day)
  • Readmission rate(1 month)
  • Pleural effusion rate after chest tube removal(1 month)
  • Duration of hospital stay(1 month)
  • Subcutaneous emphysema rate(1 month)
  • Prolonged air leak rate(1 month)

Study Sites (1)

Loading locations...

Similar Trials